Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved
Rheumatology International, 06/25/09
Thiele RG et al. – Study reports that characteristic sonographic changes are influenced by urate lowering drugs (ULDs) once serum urate (SU) levels remain ≤6 mg/dl for ≥7 months. Sonographic changes of gout correlate with SU levels and may be a non-invasive means to track changes in the uric acid pool.
Methods- Aim was to determine whether lowering SU to <6 mg/dl in pts with gout affects ultrasonographic findings
- 7 joints in 5 pts with proven gout and hyperuricemia were examined over time with serial ultrasonography
- 4/5 pts were treated with ULDs: allopurinol, n=3; probenecid, n=1
- 1 patient was treated with colchicine alone
- Attention was given to changes in a hyperechoic, irregular coating of the hyaline cartilage
- This coating was considered to represent precipitate of MSU crystals
- Index joints included metacarpophalangeal (MCP) joints (n=2), knee joints (n=3), and first metatarsophalangeal (MTP) joints (n=2)
- The interval between baseline and f/u images ranged from 7-18 mo
- Serial SU levels were obtained during the f/u period
- During the f/u period, 3 pts treated with ULD achieved a SU level of <6 mg/dl
- In 2 pts, SU levels remained above 6 mg/dl
- At baseline, the double contour sign was seen in all pts
- In those pts who achieved SU levels of <6 ml/dl, this sign had disappeared at f/u
- Disappearance of the double contour sign was seen in 2 knee joints, 2 first MTP joints, and 1 MCP joint
- In contrast, disappearance of the double contour sign was not seen in pts who maintained a SU level ≥7 mg/dl
- In 1 patient treated with allopurinol, SU levels improved from 13 to 7 mg/dl during the f/u period
- Decrease, but not resolution of the hyperechoic coating was seen in this patient
- In patient treated with colchicine alone, SU levels remained >8 mg/dl, and no sonographic change was observed
- Sonographic signs of deposition of MSU crystals on the surface of hyaline cartilage disappeared completely if sustained normouricemia was achieved
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09
Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/23/09
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


